ENTPD1 and neoplasm: In contrast, CD103+CD39+ tumor-infiltrating CD8 cells display a distinct TCR repertoire and kill tumor cells in a MHC-class-I-dependent manner via IFN-γ secretion, therefore playing an active role in the control of tumor growth (Duhen et al., 2018).